BE799102A - Composes anesthesiques de la serie du pregnane et compositions en contenant, - Google Patents

Composes anesthesiques de la serie du pregnane et compositions en contenant,

Info

Publication number
BE799102A
BE799102A BE130749A BE130749A BE799102A BE 799102 A BE799102 A BE 799102A BE 130749 A BE130749 A BE 130749A BE 130749 A BE130749 A BE 130749A BE 799102 A BE799102 A BE 799102A
Authority
BE
Belgium
Prior art keywords
anesthesic
compounds
compositions containing
pregnane series
pregnane
Prior art date
Application number
BE130749A
Other languages
English (en)
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of BE799102A publication Critical patent/BE799102A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
BE130749A 1972-05-05 1973-05-04 Composes anesthesiques de la serie du pregnane et compositions en contenant, BE799102A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (1)

Publication Number Publication Date
BE799102A true BE799102A (fr) 1973-11-05

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
BE130749A BE799102A (fr) 1972-05-05 1973-05-04 Composes anesthesiques de la serie du pregnane et compositions en contenant,

Country Status (16)

Country Link
JP (1) JPS4961150A (fr)
AT (1) AT355232B (fr)
AU (1) AU475168B2 (fr)
BE (1) BE799102A (fr)
CA (1) CA1013341A (fr)
CH (1) CH617710A5 (fr)
DE (1) DE2322532A1 (fr)
ES (1) ES414411A1 (fr)
FR (1) FR2183792B1 (fr)
GB (1) GB1430942A (fr)
IE (1) IE37596B1 (fr)
IL (1) IL42196A (fr)
LU (1) LU67546A1 (fr)
NL (1) NL7306234A (fr)
SE (1) SE400771B (fr)
ZA (1) ZA733035B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5939545A (en) * 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
ES2296594T3 (es) * 1994-02-14 2008-05-01 Euro-Celtique S.A. Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
EP3572417B1 (fr) 2011-10-14 2025-12-17 Sage Therapeutics, LLC Composés de 19-nor prégnane disubstitués 3,3, compositions et leurs utilisations
EP2806877B2 (fr) 2012-01-23 2025-01-29 Sage Therapeutics, Inc. Formulations de stéroïdes neuroactifs comprenant un complexe d'allopregnanolone et de sulfobutyl ether beta-cyclodextrine
CA2882708A1 (fr) 2012-08-21 2014-02-27 Sage Therapeutics, Inc. Procedes de traitement de l'epilepsie ou d'un etat de mal epileptique
KR102396328B1 (ko) 2013-04-17 2022-05-10 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
EP2986624B1 (fr) 2013-04-17 2020-03-25 Sage Therapeutics, Inc. Stéroïdes neuroactifs 19-nor et pour l'utilisation thérapeutique
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
AU2014308621C1 (en) 2013-08-23 2022-01-06 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
ME03809B (fr) 2014-10-16 2021-04-20 Sage Therapeutics Inc Compositions et méthodes pour traiter des troubles du snc
CN117024501A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
WO2016082789A1 (fr) 2014-11-27 2016-06-02 Sage Therapeutics, Inc. Compositions et procédés pour traiter des troubles du snc
RS61530B1 (sr) 2015-01-26 2021-04-29 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns
EP4155314A1 (fr) 2015-02-20 2023-03-29 Sage Therapeutics, Inc. Stéroïdes neuroactifs, compositions et leurs utilisations
KR20240157128A (ko) 2016-03-08 2024-10-31 세이지 테라퓨틱스, 인크. 신경활성 스테로이드, 조성물, 및 그의 용도
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
WO2018013615A1 (fr) 2016-07-11 2018-01-18 Sage Therapeutics, Inc. Stéroïdes neuroactifs substitués en c7, c12 et c16 et méthodes d'utilisation associées
SG11202112391UA (en) 2019-05-31 2021-12-30 Sage Therapeutics Inc Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
FR2183792B1 (fr) 1977-07-15
JPS4961150A (fr) 1974-06-13
AU5528473A (en) 1974-11-07
ES414411A1 (es) 1976-02-01
IE37596L (en) 1973-11-05
CH617710A5 (en) 1980-06-13
CA1013341A (en) 1977-07-05
AT355232B (de) 1980-02-25
FR2183792A1 (fr) 1973-12-21
DE2322532A1 (de) 1973-11-22
IL42196A (en) 1978-10-31
NL7306234A (fr) 1973-11-07
ZA733035B (en) 1974-04-24
LU67546A1 (fr) 1973-07-13
ATA395173A (de) 1979-07-15
SE400771B (sv) 1978-04-10
GB1430942A (en) 1976-04-07
IE37596B1 (en) 1977-08-31
IL42196A0 (en) 1973-07-30
AU475168B2 (en) 1976-08-12

Similar Documents

Publication Publication Date Title
BE799102A (fr) Composes anesthesiques de la serie du pregnane et compositions en contenant,
BE799433A (fr) Composes anesthesiques de la serie du pregnane et leur preparation
BE794482A (fr) Compositions photopolymerisables contenant des composes cis- alpha -dicarbonyliques cycliques et des sensibilisateurs choisis
IT995049B (it) Composizioni che generano gas
BE829837A (fr) Nouveaux derives du benzothiophene, leurs procedes de preparation ainsi que les compositions pharmaceutiques les contenant
BE782105A (fr) Bis(2-pyridinethiol-1-oxyde) de phenylbismuth et compositions contenantce produit.
IT990931B (it) Migliorata struttura costruttiva di miscelatore
BE806457A (fr) Composition d'email semi-conducteur
IT1006584B (it) Composizioni insetticide
BE800311A (fr) Aminohalopyridines substituees, leur preparation et compositions en contenant
BE794067A (fr) Compositions desodorisantes et contre la transpiration
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
IL41752A0 (en) Novel steroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
BE794175A (fr) Composition desodorisante
RO65953A (fr) Compositions explosifs
OA03710A (fr) Composition d'engrais.
BE803462A (fr) Composes steroides de la serie du pregnane, leur preparation et composition s en contenant
BR7302327D0 (pt) Composicoes de materias tanantes
BE795744A (fr) Compositions retardatrices d'inflammation
BE797215A (fr) Composition contenant de la protease
IL36127A0 (en) Novel esters of the pregnane series,their preparation and pharmaceutical compositions containing them
IL36608A0 (en) Halogenosteroids of the pregnane series,their manufacture and pharmaceutical compositions containing them
BE799101A (fr) Composes anesthesiques de la serie du pregnane et leur preparation
BE770832A (fr) Composes steroides de la serie de l'estrane
IL35790A0 (en) Novel steroids of the pregnane series,their preparation and pharmaceutical compositions containing them